Supplementary Figure 2 from Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab

<p>Daratumumab-mediated CD38 reduction of MM cells in the presence of PBMCs as shown by Western blot analysis.</p>